WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1992001057) EHV-4 GLYCOPROTEIN VACCINE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1992/001057    International Application No.:    PCT/GB1991/001091
Publication Date: 23.01.1992 International Filing Date: 04.07.1991
Chapter 2 Demand Filed:    16.01.1992    
IPC:
A61K 39/00 (2006.01), C07K 14/03 (2006.01), C07K 16/08 (2006.01)
Applicants: THE UNIVERSITY COURT OF THE UNIVERSITY OF GLASGOW [GB/GB]; 2 The Square, University Avenue, Glasgow G12 8QQ (GB) (For All Designated States Except US).
NICOLSON, Lesley [GB/GB]; (GB) (For US Only).
ONIONS, David, Edward [GB/GB]; (GB) (For US Only).
EQUINE VIROLOGY RESEARCH FOUNDATION [GB/GB]; 101 High Street, Newmarket, Suffolk CSB8 8JL (GB) (For All Designated States Except US)
Inventors: NICOLSON, Lesley; (GB).
ONIONS, David, Edward; (GB)
Agent: HORNER, Martin, Grenville; Cruikshank & Fairweather, 19 Royal Exchange Square, Glasgow G1 3AE (GB)
Priority Data:
9014950.1 06.07.1990 GB
Title (EN) EHV-4 GLYCOPROTEIN VACCINE
(FR) VACCIN A BASE DE GLYCOPROTEINE DE VHE-4 (VIRUS D'HERPES EQUIN-4)
Abstract: front page image
(EN)The invention is concerned with the glycoproteins gH and gC of EHV-4 which can be used to vaccinate horses against EHV-4 infection. The invention also relates to nucleic acid sequences encoding the EHV-4 gH and gC polypeptides. Said sequences can be used for the preparation of a subunit or vector vaccine.
(FR)Cette invention se rapporte aux glycoprotéines gH et gC de VHE-4 qui peuvent être utilisées pour vacciner les chevaux contre l'infection par le VHE-4. L'invention se rapporte aussi à des séquences d'acide nucléique codant les polypeptides gH et gH VHE-4. Lesdites séquences peuvent être utilisées pour la préparation d'un vaccin de sous-unité ou d'un vaccin vecteur.
Designated States: AU, CA, GB, HU, JP, KR, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, NL, SE).
Publication Language: English (EN)
Filing Language: English (EN)